Andrographis-paniculata/calcium/echinacea-angustifolia/ocimum-sanctum/andrographis-paniculata/echinacea-angustifolia/ech

  • PDF / 169,491 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 63 Downloads / 200 Views

DOWNLOAD

REPORT


1

Andrographis-paniculata/calcium/echinacea-angustifolia/ocimum-sanctum/andrographispaniculata/echinacea-angustifolia/echinacea-pallida/echinacea-purpurea/ginseng

S

Anaphylactic shock and hypersensitivity reactions: 2 case reports In a case report of 3 patients received by Health Canada (Canada Vigilance Program) as of 30 April 2020, a 56-year-old woman was described who developed anaphylactic shock during treatment with andrographis-paniculata/echinacea-angustifolia/echinaceapallida/echinacea-purpurea/ginseng and and a 40-year-old woman was described who developed hypersensitivity reactions during treatment with andrographis-paniculata/calcium/echinacea-angustifolia/ocimum-sanctum [dosages, indications and outcomes not stated]. Patient 1: A 56-year-old woman was receiving treatment with oral andrographis-paniculata/echinacea-angustifolia/echinaceapallida/echinacea-purpurea/ginseng [Cold-tek] capsules. However, within 10 minutes after receiving 2 capsules, she developed anaphylactic shock. Patient 2: A 40-year-old woman was receiving treatment with oral andrographis-paniculata/calcium/echinacea-angustifolia/ ocimum-sanctum [Andrographis complex]. However, 3 hours after receiving treatment, she developed serious hypersensitivity reactions consisting of dyspnoea, abdominal and chest pain, diarrhoea, vomiting, erythema, seizure and urticaria. canada vigilance program. Hypersensitivity reactions, including anaphylaxis, reported with oral use of Andrographis paniculata-containing natural health products Health Product InfoWatch : 1-5, Sep 2020. Available from: URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/ september-2020.html#a5.1 803505519

0114-9954/20/1825-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 10 Oct 2020 No. 1825

Data Loading...